OTC Innovation In An Age Of Pandemics – Q&A With Stada’s New R&D Head Stephen Makin

COVID-19 has shifted consumer health behaviour towards prevention and general wellbeing. However, finding out what consumers actually want and need is still the essence of good OTC innovation, according to Stada Arzneimittel's new vice president of consumer healthcare product development Steve Makin.

Brainstorming Group of people Working Concept. Business team brainstorming. Marketing plan researching. Paperwork on the table, laptop and mobile phone.
• Source: Shutterstock

We may be entering an “age of pandemics," according to Ebola co-discoverer and “Mick Jagger of microbes,” Peter Piot, who now serves as special adviser on the coronavirus to the European Commission president, Ursula von der Leven.

This will not be good news for consumer health companies, whose research and development plans for 2020 have had to be thrown out of the window thanks to the sudden appearance of COVID-19 earlier this year, and

More from Innovation & IP

More from Health